Titan Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8883143096
Pharmaceuticals
Sales 2022 | 6L 4.65Cr | Sales 2023 | 2L 1.54Cr | Capitalization | 62.15L 52Cr |
---|---|---|---|---|---|
Net income 2022 | -1Cr -83Cr | Net income 2023 | -50L -42Cr | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 27.5L 23Cr | Net cash position 2023 | 61.95L 52Cr | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15/22/15 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12/23/12 |
Brynner Chiam
BRD | Director/Board Member | - | 12/23/12 |
1st Jan change | Capi. | |
---|---|---|
+35.01% | 71TCr | |
+30.50% | 60TCr | |
-2.60% | 37TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.47% | 24TCr | |
+9.41% | 21TCr | |
-3.68% | 20TCr | |
+10.77% | 17TCr |